TY  - JOUR
AU  - Ramos, Teresa Lopes
AU  - García-Guerrero, Estefanía
AU  - Caballero-Velázquez, Teresa
AU  - Rodríguez-Gil, Alfonso
AU  - Caracuel-García, Rocío
AU  - Nufer, Melanie
AU  - Robles-Frías, María José
AU  - Barbado, María Victoria
AU  - Pérez-Simón, José A
PY  - 2021
DO  - 10.1038/s41409-021-01452-1
UR  - https://hdl.handle.net/10668/27863
T2  - Bone marrow transplantation
AB  - In this study, we aimed to modify the immune response in the long term after allogeneic bone marrow transplantation (allo-BMT) by using the proteasome inhibitor ixazomib (IXZ) at the late stages of the post-transplant period. This approach facilitated...
LA  - en
KW  - Animals
KW  - Bone Marrow Transplantation
KW  - Boron Compounds
KW  - Glycine
KW  - Graft vs Host Disease
KW  - Graft vs Leukemia Effect
KW  - Immunity
KW  - Mice
TI  - Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease.
TY  - research article
VL  - 56
ER  -